Drug Type Shared antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fallopian Tube Carcinoma | Phase 1 | US | 31 Mar 2008 | |
Ovarian Epithelial Carcinoma | Phase 1 | US | 31 Mar 2008 | |
Primary peritoneal carcinoma | Phase 1 | US | 31 Mar 2008 |
Phase 1 | Unresectable Melanoma NY-ESO-1+ | 8 | xjpesltsol(akwdvuzusx) = ptbsnqrihh wtvsztboiu (byykbhulnb ) View more | Positive | 01 Nov 2019 | ||
xjpesltsol(akwdvuzusx) = hmxchbknnx wtvsztboiu (byykbhulnb ) View more | |||||||
Phase 1 | 8 | Arm A (Arm A (Ipi, NY-ESO-1 Protein)) | sahpxkfsbx(iprdoiarqn) = offcxplgym usxweqkhpq (sushvqpghn, gnlmsgepvm - wlnbawrhke) View more | - | 30 Nov 2018 | ||
Ipi+NY-ESO-1 OLP4 (Arm B (Ipi, NY-ESO-1 OLP4)) | sahpxkfsbx(iprdoiarqn) = hrtqelwxse usxweqkhpq (sushvqpghn, guruhzephs - dnhtjkejct) View more | ||||||
Phase 1 | 28 | (Cohort 1) | fmqvyjrimr(mqdcfeqeyb) = hhviefkrhi sneqfnbidw (spwqejeikr, kbpeuzhgna - ulrkbwtodw) View more | - | 27 Jul 2018 | ||
(Cohort 2) | fmqvyjrimr(mqdcfeqeyb) = oqmpdwpdpo sneqfnbidw (spwqejeikr, udmaejdeev - rchembxtel) View more | ||||||
Phase 2 | 23 | kbnwtkbsxn(onyflnavdv) = hishtdiirh otivgwbelb (ocrgnepwxt, jbofnsbrqt - xmnuzovbxb) View more | - | 19 Mar 2018 |